Literature DB >> 12422346

Crouzon syndrome: association with absent pulmonary valve syndrome and severe tracheobronchomalacia.

Raphael Beck1, Andrea L Sertie, Riva Brik, Marwan Shinawi.   

Abstract

Airway obstruction is common among patients with craniosynostosis. We describe an infant with a clinical and genetic diagnosis of Crouzon syndrome who presented with respiratory distress and heart murmur in early neonatal life. Cardiac evaluation revealed absent pulmonary valve syndrome. She needed intubation at age 1 month, and repeated trials of extubation failed because of marked respiratory distress, stridor, and severe expiratory obstruction and wheezing. Correction of her cardiac anomaly did not relieve her respiratory distress; only after endobronchial stenting and tracheostomy was it possible to gradually wean her from mechanical ventilation. This case report demonstrates and discusses the different causes of airway obstruction in Crouzon syndrome and the morbidity and mortality that can result from pulmonary involvement in this craniosynostotic syndrome. It also demonstrates the difficult therapeutic challenge created by the combination of cardiopulmonary abnormalities in Crouzon patients. Copyright 2002 Wiley-Liss, Inc.

Entities:  

Mesh:

Year:  2002        PMID: 12422346     DOI: 10.1002/ppul.10176

Source DB:  PubMed          Journal:  Pediatr Pulmonol        ISSN: 1099-0496


  3 in total

Review 1.  Choanal Atresia and Craniosynostosis: Development and Disease.

Authors:  Kate M Lesciotto; Yann Heuzé; Ethylin Wang Jabs; Joseph M Bernstein; Joan T Richtsmeier
Journal:  Plast Reconstr Surg       Date:  2018-01       Impact factor: 4.730

2.  Clinical features of airway malacia in children: a retrospective analysis of 459 patients.

Authors:  Wei Pan; Donghong Peng; Jian Luo; Enmei Liu; Zhengxiu Luo; Jihong Dai; Zhou Fu; Qubei Li; Ying Huang
Journal:  Int J Clin Exp Med       Date:  2014-09-15

3.  Crouzon Syndrome Associated with Congenital Coarctation of Aorta.

Authors:  Bing Meng; Hui Zhang
Journal:  Chin Med J (Engl)       Date:  2018-06-20       Impact factor: 2.628

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.